gvtcx

Ustekinumab

key details

Value£6,532,463 (£7,838,955 inc. VAT)
Statuscomplete
RegionWales
Procedureopen
OCIDocds-h6vhtk-05f601

Awards (5)

This procurement was awarded to 5 suppliers. Values shown are per-award; the notice total is £6,532,463.

SupplierValueDateStatus
Amgen Ltd shared · · active
Celltrion Healthcare shared · · active
Fresenius Kabi Ltd shared · · active
Sandoz Ltd shared · · active
Thornton & Ross shared · · active

description

Contract award details for the supply of Ustekinumab

notice history

4 notices published against this procurement.

PublishedTypeRegimeNotice
15 Dec 2025 Preliminary market engagement (UK2) Procurement Act 2023 083013-2025
2 Feb 2026 Tender notice (UK4) Procurement Act 2023 009100-2026
15 Jun 2026 Contract award (UK6) Procurement Act 2023 056148-2026
11 Aug 2026 Contract details (UK7) Procurement Act 2023 076159-2026

more from NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)

all contracts from this buyer →

source

Published on Find a Tender. Contact details for named individuals are not reproduced on this site.